Tommy Beer / Forbes
Link to story
Context
- FDA warns that Abbot’s rapid COVID-19 can return false negatives; Abbot claims test is being used improperly, launching new accuracy studies (Matthew Herper / STAT)
- Unreviewed NYU study shows Abbot’s rapid coronavirus test missed between 33% – 48% of positive cases (Michelle Fay Cortez, Robert Langreth, Kristen V Brown / Bloomberg)